Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Lung Cancer 2023: Lisbon
- Start date
- 17 Nov 2023
- End date
- 18 Nov 2023
- Location
- Lisbon, Portugal
Learning objectives
- To learn the principles of pathology, molecular testing, and screening of lung cancer
- To understand current landscape of multimodality treatment of stage I - III lung cancer
- To understand the complex picture of immunotherapy and targeted therapies for lung cancer in 2023
- To familiarize with current treatment paradigms in SCLC, mesothelioma, and thymoma/thymic carcinoma
Accreditation
The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Pilar Garrido Lopez, Spain
- Rafal Dziadziuszko, Poland
Supported by
